Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04168775 · ClinicalTrials.gov registry record · NA

Peak Inspiratory Flow Rates in Patients With COPD

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT04168775 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04168775, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Recent studies have reported that some Chronic Obstructive Pulmonary Disease (COPD) patients may have a suboptimal ability to generate a sufficient inspiratory effort to achieve adequate lung delivery of inhaled medications through dry powder inhalers. Sparse data is available about the inspiratory capacity of these patients in the home setting, whether clinically stable or when experiencing worsened respiratory symptoms outside the acute care setting. This study is undertaken to better understand the proportion of patients with suboptimal peak inspiratory flow rate (sPIFR) measurements amongst COPD patients receiving dry powder inhaler(s) (DPI) in the ambulatory setting. Further, the study will characterize PIFR over time, the variability of PIFR measurements, and the associations with potential predictors (demographics, clinical, Patient-Reported Outcomes (PRO), body position, and device) as well as exacerbations frequency and change in PIFR around period of exacerbation.

Interventions

  • DEVICE Home PIFR monitoring with InCheck Dial

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-07-31
Est. Completion 2022-04-26
Phase NA

What the Registry Record Tells You About NCT04168775

The ClinicalTrials.gov registry entry for NCT04168775 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Home PIFR monitoring with InCheck Dial is the first listed.

NCT04168775 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04168775 about?

NCT04168775 is a clinical study titled "Peak Inspiratory Flow Rates in Patients With COPD". Recent studies have reported that some Chronic Obstructive Pulmonary Disease (COPD) patients may have a suboptimal ability to generate a sufficient inspiratory effort to achieve adequate lung delivery of inhaled medications through dry powder inhalers. Sparse data is available about the inspiratory ...

What is the current status of trial NCT04168775?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-07-31. Estimated completion is 2022-04-26.

What interventions are being tested in trial NCT04168775?

The interventions under investigation include: Home PIFR monitoring with InCheck Dial (DEVICE).

Who is sponsoring clinical trial NCT04168775?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.